

| カタログ番号 | AV064518 |
|---|---|
| 説明 |
Anti-Omalizumab Neutralizing Antibody ELISA kit (AV064518) — Quantitative sandwich ELISA for Anti-Omalizumab Neutralizing Antibody. Sample: Plasma, Serum. Range: 156.25 - 10, 000 ng/mL. Sensitivity: 82.6 ng/mL.
Highlights
|
| サンプルタイプ | Plasma, Serum |
| 感度 | 82.6 ng/mL |
| レンジ | 156.25 - 10, 000 ng/mL |
| アクセッション番号 | CAS: 242138-07-4 |
| アプリケーション | ELISA |
| 検出方法 | Colorimetric |
| アッセイタイプ | Quantitative |
| 回収率 | 80-120% |
| 発送 | 2-8 ℃ |
| 安定性と保存 | When the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃. |
| 仕様 | Omalizumab |
| 別名 | IGE25, olizumab, pSVIE26, rhuMab-E25, 242138-07-4 |
| 背景 | Immunoglobulin heavy constant epsilon (Omalizumab) is a ~59 kDa protein. Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. 1. Schroeder, HW. et al. (2010) The Journal of allergy and clinical immunology 125, S41-52. PMID: 20176268 2. McHeyzer-Williams, M. et al. (2011) Nature reviews. Immunology 12, 24-34. PMID: 22158414 3. Teng, G. et al. (2007) Annual review of genetics 41, 107-20. PMID: 17576170 |
| 注意事項 | For Research Use Only. |
+86-027-65523339
中国武漢市深敦寺路666号C棟、武漢、430206

中文
English
한국어
日本語
Español
Français
Русский